We study attitudes toward offering monetary payments for vaccination. We develop the Policy Lab, an experimental paradigm to characterize policy preferences in which participants decide whether to implement actual interventions to influence others' real-world behavior. In two studies with...

During 2021, most Latin American countries successfully deployed vaccines and their labor markets began to recover from the COVID-19 slump. Using two waves of the 2021 HFPS, we investigate the connection between immunization and employment recovery. We first show the highly uneven social impact...

The COVID-19 pandemic has wrought global disruptions, impacting societies and economies significantly, while vaccine hesitancy remains a pressing concern. This paper introduces a framework for analyzing vaccination decision-making, emphasizing the roles of perceived costs and social influences....

Employing newly available data on Chinese Covid-19 vaccine deliveries for a cross-section of 157 countries, we examine if China's vaccine diplomacy is driven by altruistic, enlightened self-interested motives or by purely strategic motives. According to the enlightened self-interested logic,...

This study presents empirical evidence on the impact of public funding on the vaccination rate of children under one-year-old in Vietnam from 2014 to 2019. The research findings indicate that, first, the effect of government funding on the vaccination rate of children is positive after...

In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023-24 season vaccination campaigns in the European Union/European Economic Area (EU/EEA). This report presents an interim description of COVID-19 vaccine...

Cervical cancer is the fourth most common cancer affecting women worldwide. It is caused by persistent infection with oncogenic types of human papillomavirus (HPV). More than 200 types of HPV have been identified and more than 40 types of them infect the genital tract. HPV 16 and 18 are the two...